The Technical AnalystExchange: TAI Sector: Healthcare Industry: Medical Instruments & Supplies
Nang Kuang Pharmaceutical Price, Forecast, Insider, Ratings, Fundamentals & Signals
-0.89% TWD44.60
America/New_York / 3 mai 2024 @ 01:30
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 4 504.06 mill |
| EPS: | 1.570 |
| P/E: | 28.41 |
| Earnings Date: | May 02, 2024 |
| SharesOutstanding: | 100.99 mill |
| Avg Daily Volume: | 0.234 mill |
| RATING 2024-05-03 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Sell | |
| Return On Asset: | Sell | |
| DE: | Buy | |
| P/E: | Strong Sell | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 1.53x |
| Company: PE 28.41 | sector: PE 18.55 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 1.16x |
| Company: PE 28.41 | industry: PE 24.57 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
TWD82.31 (84.56%) TWD37.71 |
| Date: 2024-05-05 |
| Expected Trading Range (DAY) |
|---|
|
TWD 43.91 - 45.29 ( +/- 1.55%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | TWD44.60 (-0.89% ) |
| Volume | 0.172 mill |
| Avg. Vol. | 0.234 mill |
| % of Avg. Vol | 73.42 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 1752.TW
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
1752.TW
Nang Kuang Pharmaceutical Co., Ltd. operates as a pharmaceutical company primarily in Taiwan. The company provides parenterals, aseptic parenterals, lyophilized injections, pre-filled syringes, and pre-mixed IV infusion bags, as well as tablets, capsules, topical products, and oral suspensions. It offers various products in the areas of cardiovascular system, gastrointestinal system, nervous system, alimentary and metabolism, blood, antineoplastic and immunomodulatory, musculo-skeletal system, respiratory system, dermatological, genito-urinary and sex hormone, systemic hormone, systemic antibacterial, and cosmetics, as well as hospital solution. In addition, the company offers sterile, anticancer injectable, injectable controlled and oral controlled products, and oral disintegration tablets. Nang Kuang Pharmaceutical Co., Ltd. was founded in 1963 and is headquartered in Tainan City, Taiwan.